Predictive Oncology Share Price Today
(NASDAQ: POAI)

Name: Predictive Oncology Share Price Today (NASDAQ: POAI) - Predictive Oncology Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Predictive Oncology share price is $1.27 & ₹110.45 as on 6 Mar 2025, 2.30 'hrs' IST

$1.27

▲

-0.02

(-1.55%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Predictive Oncology share price in Dollar and Rupees. Guide to invest in Predictive Oncology stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Predictive Oncology, along with analyst recommendations, forecasts, and comprehensive financials.

Predictive Oncology share price movements

Today's Low: $1.24
Today's High: $1.28
$1.27
2.34%
Downside
Day's Volatility :2.72%
Upside
0.39%
52 Weeks Low: $0.55
52 Weeks High: $3.11
$1.27
56.69%
Downside
52 Weeks Volatility :82.32%
Upside
59.16%

Predictive Oncology (POAI) Returns

Period	Predictive Oncology Inc	Index (Russel 2000)
3 Months	68.03%	0.0%
6 Months	38.96%	0.0%
1 Year	-54.81%	0.0%
3 Years	-93.24%	-11.6%

Predictive Oncology (POAI) Key Statistics

in dollars & INR

Previous Close	$1.29
Open	$1.27
Today's High	$1.275
Today's Low	$1.2403
Market Capitalization	$9.3M
Today's Volume	$71.9K
52 Week High	$3.11
52 Week Low	$0.55
Revenue TTM	$1.5M
EBITDA	$-13.0M
Earnings Per Share (EPS)	$-3.01
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-201.46%

How to invest in Predictive Oncology Stock (POAI) from India?

It is very easy for Indian residents to invest directly in Predictive Oncology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Predictive Oncology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Predictive Oncology or POAI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Predictive Oncology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Predictive Oncology shares which would translate to 0.685 fractional shares of Predictive Oncology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Predictive Oncology, in just a few clicks!

Returns in Predictive Oncology (POAI) for Indian investors in Rupees

The Predictive Oncology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Predictive Oncology investment value today

Current value as on today

₹50,145

Returns

₹49,855

(-49.86%)

Returns from Predictive Oncology Stock

₹54,804 (-54.8%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Predictive Oncology (POAI)

-70.18%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Predictive Oncology Shares from India has dropped by -70.18% over the past 30 days, indicating reduced transactional activity.

-80%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Predictive Oncology Stock from India on INDmoney has decreased by -80% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Predictive Oncology

Analyst Recommendation on Predictive Oncology

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Predictive Oncology(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Predictive Oncology Stock (POAI)

What analysts predicted

Upside of 136.22%

Target:

$3.00

Current:

$1.27

Insights on Predictive Oncology Stock (Ticker Symbol: POAI)

Price Movement
In the last 3 months, POAI stock has moved up by 58.2%
Increasing Revenue
Revenue is up for the last 2 quarters, 278.72K → 345.68K (in $), with an average increase of 19.4% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -4.21M → -3.09M (in $), with an average increase of 17.7% per quarter
POAI vs ISRG (1 yr)
In the last 1 year, Intuitive Surgical, Inc. has given 46.3% return, outperforming this stock by 101.1%
POAI vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 87.9% return, outperforming this stock by 180.1%
Price to Sales
ForPOAI every $1 of sales, investors are willing to pay $4.1, whereas for Intuitive Surgical, Inc., the investors are paying $24.2 for every $1 of sales.

POAI Predictive Oncology Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$1.4M	↑ 115.57%
Net Income	$-10.1M	↑ 30.21%
Net Profit Margin	-714.51%	↑ 468.47%

	FY19	Y/Y Change
Revenue	$1.4M	↓ 0.01%
Net Income	$-27.6M	↑ 173.2%
Net Profit Margin	-2.0K%	↓ 1237.66%

	FY20	Y/Y Change
Revenue	$1.3M	↓ 11.28%
Net Income	$-37.7M	↑ 36.82%
Net Profit Margin	-3.0K%	↓ 1058.49%

	FY21	Y/Y Change
Revenue	$1.4M	↑ 13.45%
Net Income	$-19.7M	↓ 47.86%
Net Profit Margin	-1.4K%	↑ 1627.01%

	FY22	Y/Y Change
Revenue	$1.5M	↑ 5.97%
Net Income	$-36.2M	↑ 84.2%
Net Profit Margin	-2.4K%	↓ 1021.43%

	FY23	Y/Y Change
Revenue	$1.8M	↑ 18.24%
Net Income	$-14.0M	↓ 61.38%
Net Profit Margin	-785.58%	↑ 1619.5%

	Q2 FY23	Q/Q Change
Revenue	$490.1K	↑ 104.3%
Net Income	$-3.9M	↓ 7.84%
Net Profit Margin	-800.51%	↑ 974.07%

	Q3 FY23	Q/Q Change
Revenue	$715.1K	↑ 45.9%
Net Income	$-3.2M	↓ 19.37%
Net Profit Margin	-442.41%	↑ 358.1%

	Q4 FY23	Q/Q Change
Revenue	$335.0K	↓ 53.15%
Net Income	$-3.5M	↑ 9.86%
Net Profit Margin	-1.0K%	↓ 594.91%

	Q1 FY24	Q/Q Change
Revenue	$419.6K	↑ 25.26%
Net Income	$-4.2M	↑ 21.39%
Net Profit Margin	-1.0K%	↑ 31.99%

	Q2 FY24	Q/Q Change
Revenue	$278.7K	↓ 33.58%
Net Income	$-3.2M	↓ 24.59%
Net Profit Margin	-1.1K%	↓ 136.04%

	Q3 FY24	Q/Q Change
Revenue	$345.7K	↑ 24.03%
Net Income	$-3.1M	↓ 2.72%
Net Profit Margin	-895.23%	↑ 246.14%

	FY18	Y/Y Change
Profit	$995.9K	↑ 96.51%

	FY19	Y/Y Change
Profit	$879.8K	↓ 11.66%

	FY20	Y/Y Change
Profit	$805.1K	↓ 8.49%

	FY21	Y/Y Change
Profit	$933.7K	↑ 15.97%

	FY22	Y/Y Change
Profit	$1.0M	↑ 7.14%

	FY23	Y/Y Change
Profit	$1.1M	↑ 14.49%

	Q2 FY23	Q/Q Change
Profit	$330.3K	↑ 175.85%

	Q3 FY23	Q/Q Change
Profit	$608.1K	↑ 84.08%

	Q4 FY23	Q/Q Change
Profit	$-71.3K	↓ 111.72%

	Q1 FY24	Q/Q Change
Profit	$69.7K	↓ 197.76%

	Q2 FY24	Q/Q Change
Profit	$-38.4K	↓ 155.14%

	Q3 FY24	Q/Q Change
Profit	$148.8K	↓ 487.3%

	FY18	Y/Y Change
Operating Cash Flow	$-5.3M	↑ 18.57%
Investing Cash Flow	$-1.1M	↓ 32.81%
Financing Cash Flow	$5.8M	↑ 13.29%

	FY19	Y/Y Change
Operating Cash Flow	$-8.7M	↑ 65.14%
Investing Cash Flow	$-599.1K	↓ 46.06%
Financing Cash Flow	$9.3M	↑ 60.84%

	FY20	Y/Y Change
Operating Cash Flow	$-12.3M	↑ 40.37%
Investing Cash Flow	$-167.5K	↓ 72.05%
Financing Cash Flow	$13.0M	↑ 38.97%

	FY21	Y/Y Change
Operating Cash Flow	$-12.2M	↓ 0.4%
Investing Cash Flow	$-10.6M	↑ 6234.52%
Financing Cash Flow	$50.3M	↑ 288.65%

	FY22	Y/Y Change
Operating Cash Flow	$-12.4M	↑ 1.33%
Investing Cash Flow	$-475.7K	↓ 95.52%
Financing Cash Flow	$6.7M	↓ 86.66%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-3.6M	↑ 4.27%
Investing Cash Flow	$-259.1K	↑ 0.0%
Financing Cash Flow	$0.0	↓ 100.0%

Predictive Oncology Technicals Summary

Sell

Neutral

Buy

Predictive Oncology is currently in a neutral trading position according to technical analysis indicators.

Predictive Oncology (POAI) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Predictive Oncology Inc	-15.33%	38.96%	-54.81%	-93.24%	-97.11%
Intuitive Surgical, Inc.	-2.01%	19.16%	46.34%	94.07%	233.7%
Alcon Ag	3.44%	0.33%	10.46%	30.15%	67.23%
Resmed Inc.	-6.92%	-8.56%	21.46%	-9.48%	44.87%
Becton, Dickinson And Company	-7.55%	-3.91%	-4.87%	-18.81%	-2.89%
Cooper Companies Inc., The	-4.17%	-14.24%	-10.35%	-8.95%	15.06%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Predictive Oncology Inc	NA	NA	NA	0.0	-2.01	-0.66	NA	0.3
Intuitive Surgical, Inc.	88.57	88.57	3.92	8.06	0.16	0.09	NA	46.08
Alcon Ag	45.84	45.84	2.88	3.26	0.05	0.03	0.0	43.58
Resmed Inc.	27.56	27.56	1.52	9.47	0.26	0.14	0.01	35.77
Becton, Dickinson And Company	38.47	38.47	1.04	14.42	0.07	0.04	0.02	87.78
Cooper Companies Inc., The	46.74	46.74	9.59	3.98	0.05	0.04	NA	40.5

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Predictive Oncology Inc	Buy	$9.3M	-97.11%	NA	0.0%
Intuitive Surgical, Inc.	Buy	$199.0B	233.7%	88.57	27.81%
Alcon Ag	Buy	$45.8B	67.23%	45.84	10.27%
Resmed Inc.	Buy	$34.0B	44.87%	27.56	25.35%
Becton, Dickinson And Company	Buy	$64.4B	-2.89%	38.47	8.37%
Cooper Companies Inc., The	Buy	$18.1B	15.06%	46.74	10.07%

About Predictive Oncology

Predictive Oncology Inc., a knowledge and science-driven company, applies artificial intelligence (AI) to support the discovery and development of optimal cancer therapies. It operates through three segments: Pittsburgh, Birmingham, and Eagan. The Pittsburgh segment provides services that include the application of AI using its proprietary biobank of approximately 150,000 tumor samples and creates proprietary 3D culture models used in drug development. The Birmingham segment offers contract services and research focused on solubility improvements, stability studies, and protein production. The Eagan segment produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. The company was formerly known as Precision Therapeutics Inc. and changed its name to Predictive Oncology Inc. in June 2019. Predictive Oncology Inc. was incorporated in 2002 and is based in Pittsburgh, Pennsylvania.

Organization	Predictive Oncology
Employees	34
CEO	Mr. Raymond F. Vennare
Industry	Health Technology

Management People of Predictive Oncology

Name	Title
Mr. Raymond F. Vennare	CEO & Chairman
Mr. Joshua Blacher M.B.A.	Interim Chief Financial Officer
Dr. Lawrence J. DeLucas D.Sc, O.D, Ph.D.	Senior Vice President of Biologics
Dr. Arlette H. Uihlein FCAP, M.D.	Senior VP of Translational Medicine & Drug Discovery and Medical Director

Important FAQs about investing in POAI Stock from India :

What is Predictive Oncology share price today?

Predictive Oncology share price today stands at $1.27, Open: $1.27 ; Previous Close: $1.29 ; High: $1.28 ; Low: $1.24 ; 52 Week High: $3.11 ; 52 Week Low: $0.55.

The stock opens at $1.27, after a previous close of $1.29. The stock reached a daily high of $1.28 and a low of $1.24, with a 52-week high of $3.11 and a 52-week low of $0.55.

Can Indians buy Predictive Oncology shares?

Yes, Indians can invest in the Predictive Oncology (POAI) from India.

With INDmoney, you can buy Predictive Oncology at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Predictive Oncology at zero transaction cost.

How can I buy Predictive Oncology shares from India?

It is very easy to buy Predictive Oncology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Predictive Oncology (POAI) be purchased?

Yes, you can buy fractional shares of Predictive Oncology with INDmoney app.

What are the documents required to start investing in Predictive Oncology stocks?

To start investing in Predictive Oncology, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.